Condition: Anal Fistula · Sponsor: Weill Medical College of Cornell University
The purpose of this study is to determine if endothelial cells derived from human umbilical vein are safe for use in conjunction with fistulotomy for the treatment of simple anal fistulas. Endothelial cells are a special kind of cell in the body that line the inside surface of blood vessels. The goal of the study is to evaluate the preliminary safety of human umbilical vein cells in anal fistula healing.
This description comes directly from the study's public registry record.
KM Muktasid · 646-962-2789 · kmm4010@med.cornell.edu
Ananya Sen · 646-962-6445 · ase4003@med.cornell.edu
Always discuss trial participation with your own doctor first.
| Weill Cornell Medical College - NewYork-Presbyterian Hospital | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04190862